Ep. 634 Heart Disease Risk, Lipids, and Imaging |Menopause, Perimenopause, Heart Health

Everyday Wellness: Midlife Hormones, Menopause, and Science for Women 35+

Welcome to this week’s Midlife Minute episode!

Statistically, one in three women will die of heart disease. So, today, we’re answering some of the many questions I received about lipids and heart health. Although I’ve done other lipid-focused Midlife Minutes before, this episode is yet another dedicated to Dr. Tom Dayspring, as I’ve received such a vast number of questions on this particular topic.   

IN THIS EPISODE, YOU WILL LEARN:

  • Why understanding your ApoB and Lp(a) is an essential part of assessing your cardiovascular risk

  • Why treatments for lipid abnormalities should be individualized to fit each specific abnormality 

  • Essential lifestyle measures for supporting overall cardiovascular health

  • How CAC scoring, CT coronary angiography, and Clearly AI-assisted imaging differ, what each test measures, and their limitations 

  • How cardiovascular disease can sometimes present differently in women 

  • Why are premature atrial contractions and premature ventricular contractions often benign when the heart is structurally normal?

  • How the roles of statins, ezetimibe, PCSK9 inhibitors, GLP-1 medications, and emerging RNA therapies differ, and why they should not be considered interchangeable

  • How declining estrogen impacts cardiovascular health

Connect with Cynthia Thurlow  

More description

Welcome to this week’s Midlife Minute episode!

Statistically, one in three women will die of heart disease. So, today, we’re answering some of the many questions I received about lipids and heart health. Although I’ve done other lipid-focused Midlife Minutes before, this episode is yet another dedicated to Dr. Tom Dayspring, as I’ve received such a vast number of questions on this particular topic.   

IN THIS EPISODE, YOU WILL LEARN:

  • Why understanding your ApoB and Lp(a) is an essential part of assessing your cardiovascular risk

  • Why treatments for lipid abnormalities should be individualized to fit each specific abnormality 

  • Essential lifestyle measures for supporting overall cardiovascular health

  • How CAC scoring, CT coronary angiography, and Clearly AI-assisted imaging differ, what each test measures, and their limitations 

  • How cardiovascular disease can sometimes present differently in women 

  • Why are premature atrial contractions and premature ventricular contractions often benign when the heart is structurally normal?

  • How the roles of statins, ezetimibe, PCSK9 inhibitors, GLP-1 medications, and emerging RNA therapies differ, and why they should not be considered interchangeable

  • How declining estrogen impacts cardiovascular health

Connect with Cynthia Thurlow  

2026-08-27 24 min
Listen elsewhere

Available Results

Generated results are saved to your library for reuse and search.

No generated results are available for this episode yet.

Transcript

No transcript is available for this episode yet.
Sign in to generate a transcript for review.
Sign in

Chapters

No chapters available.